Navigation Links
GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
Date:11/26/2007

OTC MEVACOR 20 mg taken once daily to help lower cholesterol. OTC MEVACOR 20 mg is proposed for use in women age 55 and older and men age 45 and older with moderately elevated cholesterol and one or more heart disease risk factors.

About prescription MEVACOR

MEVACOR is a prescription medicine that is approved in the United States for the treatment of elevated cholesterol levels that lifestyle changes alone cannot control and to reduce the risk of first heart attack, unstable angina and coronary revascularization procedures in healthy men and women with average or moderately elevated cholesterol levels.

According to the prescribing information, MEVACOR should not be used by anyone allergic to any of its components, people with liver disease, or by women who are pregnant, breast-feeding or likely to become pregnant. It is recommended that liver function tests be performed in all patients prior to daily use of MEVACOR 40 mg or more.

Muscle pain or weakness in patients taking prescription MEVACOR should be reported to a doctor because these could be signs of a serious side effect. Patients should tell their doctors about other medications they are taking in order to avoid possible drug interactions.

The most common adverse events reported with MEVACOR 20 mg taken once a day were diarrhea, flatulence, headache and myalgia.

About GSK

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit GlaxoSmithKline at http://www.gsk.com.

Nicorette, NicoDerm CQ and alli trademarks are either owned by and/or licensed to GSK or associated companies. Xenical is a registered trademark of the Roche Group.

About GSK Consumer Healthcare

OTC MEVACOR would be marketed in the United States by
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
9. Southwest Ambulance Awarded Exclusive, 3-Year Contract Extension in Peoria, Arizona
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Pearson VUE Signs Exclusive Contract with Educational Resources, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... (PRWEB) May 24, 2013 Gift ... Cards, major competitors in sustainable card material, are ... using forest materials as a sustainable gift card ... to identify industry challenges and increase education and ... programs to support the reduction of carbon footprint ...
(Date:5/24/2013)... 2013 Started in 1982, AMTC’s SHINE event ... 2013 marks AMTC’s 31st anniversary. SHINE is a ministry run ... Millie Lewis and her daughter, Carey Lewis Arban. , This ... directors, and music professionals including the New York Film Academy, ... They are kings of Hollywood and Christian casting directors. They ...
(Date:5/24/2013)... replicate what appeared to be breakthrough results for the ... last year in the journal Science . , ... the drug bexarotene (marketed as Targretin) could rapidly reverse ... pathological hallmark of Alzheimer,s disease in the brains ... report, drug treatment quickly removed most of the plaques ...
(Date:5/24/2013)... Salt Lake City, Utah (PRWEB) May 24, 2013 ... AnatomyOne 2.0 , with exciting new enhancements for instructors ... help students stay more focused through personalize learning plan ... the new AnatomyOne release provides 500 new assessment questions, ... make and review notes. , AnatomyOne 2.0 ...
(Date:5/24/2013)... Los Angeles, CA (PRWEB) May 24, 2013 ... is to present the 3rd Annual EB-5 Investment Summit: ... 2013. The Dealmakers Conference will focus on exploring alternative ... provide the latest market, legal and economic information, and ... legal professionals within the EB-5 industry. , "Our ...
Breaking Medicine News(10 mins):Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 2Health News:Multiple research teams unable to confirm high-profile Alzheimer's study 3Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Brian Su Organizes 3rd Annual EB-5 Investment Conference in Long Beach, California 2
... claim against City of New York and New York City Police ... ... 2008 -- http://thesandersfirm.com/attorney.asp?attorneyid=14 [Marc Grossman], senior partner of leading ... & Grossman, P.C. in Bronx, New York, today announced that his ...
... Inc. (PST) (OTC Bulletin Board: PSTX) announced today that ... a first closing of a,private placement. The proceeds will ... Medical subsidiary. Investors in the first,closing of the private ... a price of $1.25 per share and received a ...
... 27 Replidyne, Inc.,(Nasdaq: RDYN ) today ... employee headcount by approximately 80% to 5 employees ... September 2008 and October,2008. As a result of ... REP3123, its investigational agent for the,treatment of Clostridium ...
... will gain access to innovative medical, education and ... satellite, radio channel created for medical professionals by ... XM 157 announced today a new,strategic programming partnership ... oldest and largest, independent,association for physicians-in-training., Gary ...
... long known that teens are less likely than other ... from the Meharry-State Farm Alliance at Meharry Medical College ... passengers may be an even bigger problem. , In ... driver and passenger seat belt use for a nationally ...
... to make insulin-resistant proteins, study says , , WEDNESDAY, Aug. 27 ... compared to those in lean people, a new study shows. ... , a group of researchers from the Temple University School ... six lean and six obese people. , They found significant ...
Cached Medicine News:Health News:New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers 2Health News:Patient Safety Technologies Closes on $2.325 Million in Equity Financing 2Health News:Replidyne Announces Restructuring of Operations 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 2Health News:ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association 3Health News:Teens making poor choices when it comes to riding in vehicles 2
(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...
(Date:5/23/2013)... Mich. , May 23, 2013  Every day, their ... of air to his lungs. April and Bryan ... dire predictions weren,t true. "Quite a few doctors ... hospital alive," says April Gionfriddo , about ... desperate. Anything that would work, we would take it and ...
(Date:5/23/2013)... 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical company ... today announced that it has initiated dosing in a ... daily, oral therapy for the treatment of HCV infection. This ... is designed to assess both the safety and antiviral ... drug for the treatment of chronic HCV infections and ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3
... Cambridge Temperature Concepts (CTC), the company behind the ... I Award by the Wireless-Life Sciences Alliance (WLSA) ... . DuoFertility uses wireless technology to predict when ovulation will ... possible chance of conceiving naturally. News of this win follows ...
... Nepstar Chain Drugstore Ltd. (NYSE: NPD ) ... in China based on the number of directly operated ... first quarter ended March 31, 2011. ... Revenue increased by 9.0% to RMB618.1 million (US$94.4 ...
Cached Medicine Technology:Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 2Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 3Cambridge Temperature Concepts Wins Prestigious Award From the Wireless-Life Sciences Alliance for Fertility Monitor DuoFertility 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 2China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 3China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 4China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 5China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 6China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 7China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 8China Nepstar Chain Drugstore Reports First Quarter 2011 Financial Results 9
A simple solution to hand assisted laparoscopic surgery....
... The HandPort Systems non-adhesive ... during Hand-Assisted Laparoscopic Surgrery (HALS) ... touch, grasp, and palpate throughout. ... small as 6 cm, patients ...
... 200 series offers a range of ... The design delivers therapy to meet ... promote results in commercial and clinical ... differentiator in the SleepStyle 200 series ...
The SleepStyle 600 series with ThermoSmart delivers humidification with anti-rainout benefits. ThermoSmart technology offers a heated breathing tube that allows the constant delivery of optimal level...
Medicine Products: